Business Description
180 Life Sciences Corp
NAICS : 325412
SIC : 2834
ISIN : US68236V2034
Share Class Description:
ATNF: Ordinary SharesDescription
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.06 | |||||
| Equity-to-Asset | 0.36 | |||||
| Debt-to-Equity | 0.87 | |||||
| Debt-to-EBITDA | -1.09 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 33.9 | |||||
| 3-Year EPS without NRI Growth Rate | 41.7 | |||||
| 3-Year FCF Growth Rate | 29 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.99 | |||||
| 9-Day RSI | 37.22 | |||||
| 14-Day RSI | 38.54 | |||||
| 6-1 Month Momentum % | 54.11 | |||||
| 12-1 Month Momentum % | -36.37 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.19 | |||||
| Quick Ratio | 0.19 | |||||
| Cash Ratio | 0.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -98 | |||||
| Shareholder Yield % | -15.56 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -748.68 | |||||
| ROA % | -55.67 | |||||
| ROIC % | -131.58 | |||||
| ROCE % | -416.53 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.51 | |||||
| EV-to-EBIT | -2.23 | |||||
| EV-to-EBITDA | -2.29 | |||||
| EV-to-Forward-Revenue | 1.7 | |||||
| EV-to-FCF | -2.55 | |||||
| Earnings Yield (Greenblatt) % | -44.84 | |||||
| FCF Yield % | -72.8 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ATNF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
180 Life Sciences Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -4.815 | ||
| Beta | 0.41 | ||
| Volatility % | 159.64 | ||
| 14-Day RSI | 38.54 | ||
| 14-Day ATR ($) | 0.28035 | ||
| 20-Day SMA ($) | 2.0695 | ||
| 12-1 Month Momentum % | -36.37 | ||
| 52-Week Range ($) | 1.16 - 17.75 | ||
| Shares Outstanding (Mil) | 1.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
180 Life Sciences Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
180 Life Sciences Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
180 Life Sciences Corp Frequently Asked Questions
What is 180 Life Sciences Corp(ATNF)'s stock price today?
The current price of ATNF is $2.99. The 52 week high of ATNF is $17.75 and 52 week low is $1.16.
When is next earnings date of 180 Life Sciences Corp(ATNF)?
The next earnings date of 180 Life Sciences Corp(ATNF) is 2025-02-14 Est..
Does 180 Life Sciences Corp(ATNF) pay dividends? If so, how much?
180 Life Sciences Corp(ATNF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers